With the popularity of No/Lo Alcohol products gaining even more traction in 2026, why leave compliance as an afterthought when analyzing in-process and final products? R-Biopharm’s Enzytec&tr
Constellation Brands Second Quarter Fiscal 2027 Earnings Recap
Constellation Brands reported Q2 FY2027 results, led by beer share gains, wine and spirits growth, and reaffirmed its full-year outlook.


0 Comments